Apotex Health Corp. (TSX:APTX)
Canada · Delayed Price · Currency is CAD 33.25
-0.74 (-2.18%)
At close: Sep 18, 2026
Apotex Health Balance Sheet
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 |
Cash & Equivalents | 258.76 | 56.99 | 77.97 | 421.35 |
Cash & Short-Term Investments | 258.76 | 56.99 | 77.97 | 421.35 |
Cash Growth | - | -26.90% | -81.49% | - |
Accounts Receivable | 939.75 | 820.46 | 876.02 | 721.07 |
Other Receivables | 114.65 | 237.29 | 134.77 | 215.35 |
Receivables | 1,054 | 1,058 | 1,011 | 936.42 |
Inventory | 949.19 | 930.04 | 973.57 | 832.2 |
Prepaid Expenses | - | 59.64 | 25.65 | 35.84 |
Other Current Assets | 210.19 | 69 | 235.35 | 218.1 |
Total Current Assets | 2,473 | 2,173 | 2,323 | 2,444 |
Property, Plant & Equipment | 1,126 | 1,131 | 1,142 | 1,110 |
Goodwill | 296.26 | 295.12 | 296.27 | 86.94 |
Other Intangible Assets | 755.57 | 759.13 | 765.26 | 127.3 |
Long-Term Deferred Tax Assets | 168.51 | 166.35 | 288.67 | 203.62 |
Other Long-Term Assets | 42.38 | 19.33 | 36.68 | 66 |
Total Assets | 4,861 | 4,544 | 4,852 | 4,038 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 |
Accounts Payable | 1,005 | 190.48 | 150.09 | 93.17 |
Accrued Expenses | - | 650.64 | 614.65 | 547.17 |
Current Portion of Long-Term Debt | 102.73 | 101.21 | 108.42 | 34.69 |
Current Portion of Leases | 10.7 | 11.44 | 8.67 | 5.55 |
Current Income Taxes Payable | 34.2 | 33.81 | 79.58 | 133.73 |
Other Current Liabilities | 245.43 | 461.15 | 706.51 | 522.24 |
Total Current Liabilities | 1,398 | 1,449 | 1,668 | 1,337 |
Long-Term Debt | 2,331 | 2,839 | 1,959 | 1,291 |
Long-Term Leases | 578.33 | 569.01 | 573.74 | 542.64 |
Long-Term Deferred Tax Liabilities | 112.83 | 127.78 | 130.47 | 10.08 |
Other Long-Term Liabilities | 90.35 | 117.41 | 230.17 | 125.81 |
Total Liabilities | 4,511 | 5,102 | 4,561 | 3,306 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 |
Common Stock | 1,118 | 308.66 | 449.61 | 910.02 |
Additional Paid-In Capital | 245.45 | 108.82 | 99.52 | 45.4 |
Retained Earnings | -1,005 | -967.05 | -231.21 | -218.95 |
Comprehensive Income & Other | -7.86 | -8.36 | -27.34 | -3.94 |
Shareholders' Equity | 350.19 | -557.93 | 290.59 | 732.53 |
Total Liabilities & Equity | 4,861 | 4,544 | 4,852 | 4,038 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 |
Total Debt | 3,022 | 3,521 | 2,650 | 1,874 |
Net Cash (Debt) | -2,764 | -3,464 | -2,572 | -1,452 |
Net Cash Growth | - | - | - | - |
Net Cash Per Share | -14.17 | -17.94 | -13.56 | -8.12 |
Filing Date Shares Outstanding | 228.5 | 192.99 | 192.99 | 178.74 |
Total Common Shares Outstanding | 228.5 | 192.99 | 192.99 | 178.74 |
Working Capital | 1,074 | 724.68 | 655.4 | 1,107 |
Book Value Per Share | 1.53 | -2.89 | 1.51 | 4.10 |
Tangible Book Value | -701.64 | -1,612 | -770.94 | 518.28 |
Tangible Book Value Per Share | -3.07 | -8.35 | -3.99 | 2.90 |
Land | - | 77.89 | 93.03 | 92.5 |
Buildings | - | 107.08 | 92.26 | 60.53 |
Machinery | - | 701.47 | 634.96 | 539.13 |